Compare AMWD & CGEM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AMWD | CGEM |
|---|---|---|
| Founded | 1980 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Forest Products | Biotechnology: Pharmaceutical Preparations |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 872.8M | 780.4M |
| IPO Year | 1995 | 2020 |
| Metric | AMWD | CGEM |
|---|---|---|
| Price | $55.49 | $14.09 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 10 |
| Target Price | ★ $66.00 | $28.80 |
| AVG Volume (30 Days) | 149.1K | ★ 665.1K |
| Earning Date | 01-01-0001 | 03-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 1.42 | N/A |
| Revenue | ★ $1,709,585,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $2.63 | N/A |
| P/E Ratio | $38.72 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $47.15 | $5.68 |
| 52 Week High | $72.95 | $14.51 |
| Indicator | AMWD | CGEM |
|---|---|---|
| Relative Strength Index (RSI) | 39.60 | 66.84 |
| Support Level | $51.70 | $11.43 |
| Resistance Level | $58.48 | N/A |
| Average True Range (ATR) | 2.92 | 0.94 |
| MACD | -1.08 | 0.17 |
| Stochastic Oscillator | 10.16 | 84.38 |
American Woodmark Corp manufactures and distributes cabinets and vanities for the remodeling and new home construction markets. It offers several products that fall into product lines including kitchen cabinetry, bath cabinetry, office cabinetry, home organization, and hardware. The products are sold under the brand names American Woodmark, Timberlake, Shenandoah Cabinetry, and Waypoint Living Spaces among others.
Cullinan Therapeutics Inc is a biopharmaceutical company. It has a diversified portfolio of clinical-stage assets that inhibit key drivers of disease or harness the immune system to eliminate diseased cells in both oncology and autoimmune diseases. Its understanding of oncology, immunology, and translational medicine, creates differentiated ideas, identifies the appropriate targets, and selects the optimal modality to develop transformative therapeutics across a variety of cancer and autoimmune indications. It has one reporting and one operating segment, which is the business of developing immunology and oncology therapies.